Assignee
BASILEA PHARMACEUTICA AG
CH·47 granted patents·5 pending applications·179 citations·filing 1998–2018
Top patents by PatentIndex Score
52 records- 0194US6812238B1N-substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 2, 2004·47 cites·19 claims
- 0287US6821980B1Substituted 5-benzyl-2,4-diaminopyrimidinesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Nov 23, 2004·30 cites·28 claims
- 0383US7459561B2N-substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Dec 2, 2008·3 cites·21 claims
- 0482US6504025B2Process for the preparation of vinyl-pyrrolidinone cephalosporin derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Jan 7, 2003·14 cites·16 claims
- 0581US9970938B2Use of BUBR1 as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2016·Granted May 15, 2018·2 cites·60 claims
- 0677US10067120B2Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2016·Granted Sep 4, 2018·2 cites·59 claims
- 0777US7524823B2MacrolidesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Apr 28, 2009·5 cites·15 claims
- 0875US7816537B2Process for the manufacture of epoxybutanol intermediatesBASILEA PHARMACEUTICA AG·Filed 2006·Granted Oct 19, 2010·1 cites·17 claims
- 0973US8927542B2Bicyclic antibioticsBASILEA PHARMACEUTICA AG·Filed 2014·Granted Jan 6, 2015·2 cites·34 claims
- 1070US7423157B2Substituted benzimidazoles and their use for inducing apoptosisBASILEA PHARMACEUTICA AG·Filed 2006·Granted Sep 9, 2008·1 cites·6 claims
- 1170US7151182B2Intermediates for N-substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Dec 19, 2006·3 cites·10 claims
- 1269US6420166B2Process for the preparation of D-asparagine derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Jul 16, 2002·2 cites·8 claims
- 1368US6995143B2Macrolides with antibacterial activityBASILEA PHARMACEUTICA AG·Filed 2003·Granted Feb 7, 2006·3 cites·57 claims
- 1467US9511064B2Combination therapy for the treatment of cancer and immunosuppressionBASILEA PHARMACEUTICA AG·Filed 2013·Granted Dec 6, 2016·2 cites·25 claims
- 1567US8933073B2Macrolides and their useBASILEA PHARMACEUTICA AG·Filed 2014·Granted Jan 13, 2015·1 cites·25 claims
- 1667USRE42890EFurazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Nov 1, 2011·4 cites·39 claims
- 1767US6828442B2Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium saltsBASILEA PHARMACEUTICA AG·Filed 2001·Granted Dec 7, 2004·2 cites·2 claims
- 1867US6437142B1Process for preparing retiferol derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Aug 20, 2002·5 cites·4 claims
- 1965US7385061B2FurazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Jun 10, 2008·3 cites·17 claims
- 2064US9133219B2Bicyclic antibioticsBASILEA PHARMACEUTICA AG·Filed 2014·Granted Sep 15, 2015·0 cites·21 claims
- 2164US6384214B1Process for producing cephalosporin derivativesBASILEA PHARMACEUTICA AG·Filed 2000·Granted May 7, 2002·3 cites·18 claims
- 2263US7262307B21′-benzyl-3-bromo-[1,3′]bipyrrolidinyl-2-oneBASILEA PHARMACEUTICA AG·Filed 2004·Granted Aug 28, 2007·2 cites·1 claims
- 2361US10724072B2Use of phospho-Akt as a biomarker of drug responseBASILEA PHARMACEUTICA AG·Filed 2018·Granted Jul 28, 2020·0 cites·65 claims
- 2461US10656162B2Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2018·Granted May 19, 2020·0 cites·48 claims
- 2561US7189858B2N-phenyl substituted carbamoyloxyalkyl-azolium derivativesBASILEA PHARMACEUTICA AG·Filed 2004·Granted Mar 13, 2007·1 cites·20 claims
- 2661US6589989B1Treatment of cell-mediated immune diseasesBASILEA PHARMACEUTICA AG·Filed 1998·Granted Jul 8, 2003·18 cites·8 claims
- 2761US6376491B1Bicyclic compoundsBASILEA PHARMACEUTICA AG·Filed 1999·Granted Apr 23, 2002·20 cites·44 claims
- 2860US9783508B2Process for the manufacture of isavuconazole or ravuconazoleBASILEA PHARMACEUTICA AG·Filed 2013·Granted Oct 10, 2017·1 cites·20 claims
- 2960US6849709B2Aerothricin derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Feb 1, 2005·1 cites·13 claims
- 3059US7951957B2Substituted benzimidazoles and their use for inducing apoptosisBASILEA PHARMACEUTICA AG·Filed 2008·Granted May 31, 2011·0 cites·25 claims
- 3156US9163034B2Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and useBASILEA PHARMACEUTICA AG·Filed 2014·Granted Oct 20, 2015·0 cites·11 claims
- 3254US9738676B2Selected macrolides with PDE4-inhibiting activityBASILEA PHARMACEUTICA AG·Filed 2013·Granted Aug 22, 2017·0 cites·11 claims
- 3354US9120822B2Tricyclic antibioticsBASILEA PHARMACEUTICA AG·Filed 2014·Granted Sep 1, 2015·0 cites·46 claims
- 3454US2005042278A1New formulation for retinoid-containing soft gelatin capsulesBASILEA PHARMACEUTICA AG·Filed 2004·Application pending·0 cites
- 3553US8809315B2Combination medicaments for treating bacterial infectionsBASILEA PHARMACEUTICA AG·Filed 2013·Granted Aug 19, 2014·0 cites·20 claims
- 3653US7531650B2Cephalosporin salts in crystalline formBASILEA PHARMACEUTICA AG·Filed 2004·Granted May 12, 2009·0 cites·6 claims
- 3751US10221206B2Selected macrolides with PDE4-inhibiting activityBASILEA PHARMACEUTICA AG·Filed 2017·Granted Mar 5, 2019·0 cites·2 claims
- 3851US9346799B2Useful combinations of monobactam antibiotics with beta-lactamase inhibitorsBASILEA PHARMACEUTICA AG·Filed 2014·Granted May 24, 2016·0 cites·5 claims
- 3950US2007167505A1Substituted benzimidazoles and their use for inducing apoptosisBASILEA PHARMACEUTICA AG·Filed 2005·Application pending·0 cites
- 4047US7064199B2Process for the manufacture of 3-amino-pyrrolidine derivativesBASILEA PHARMACEUTICA AG·Filed 2003·Granted Jun 20, 2006·0 cites·1 claims
- 4146US7115643B2Intermediate halophenyl derivatives and their use in a process for preparing azole derivativesBASILEA PHARMACEUTICA AG·Filed 2002·Granted Oct 3, 2006·0 cites·28 claims
- 4246US6403346B1Enzymatic processes for producing intermediates useful in the manufacture of retiferol derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Jun 11, 2002·0 cites·4 claims
- 4346US6310262B1Process for preparing retiferol derivativesBASILEA PHARMACEUTICA AG·Filed 2000·Granted Oct 30, 2001·0 cites·5 claims
- 4446US2008032962A1Stabilized Freeze-Dried Formulation for Cephalosporin DerivativesBASILEA PHARMACEUTICA AG·Filed 2005·Application pending·0 cites
- 4545US10590092B2Process for the manufacture of isavuconazole or ravuconazoleBASILEA PHARMACEUTICA AG·Filed 2017·Granted Mar 17, 2020·0 cites·3 claims
- 4641US6818649B2Chromenylmethyl pyrimidinediamines as antibacterial agentsBASILEA PHARMACEUTICA AG·Filed 2001·Granted Nov 16, 2004·0 cites·11 claims
- 4741US6703397B2Pyrimidinyl methyl indole derivatives with antibacterial activityBASILEA PHARMACEUTICA AG·Filed 2001·Granted Mar 9, 2004·0 cites·14 claims
- 4841US2016122320A1Useful combinations of monobactam antibiotics with beta-lactamase inhibitorsBASILEA PHARMACEUTICA AG·Filed 2016·Application pending·0 cites
- 4940US6319933B1Azole derivativesBASILEA PHARMACEUTICA AG·Filed 2001·Granted Nov 20, 2001·0 cites·15 claims
- 5031US6489440B1Cyclic compoundsBASILEA PHARMACEUTICA AG·Filed 1999·Granted Dec 3, 2002·1 cites·51 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →